PULM
PULM
NASDAQ · Pharmaceuticals

Pulmatrix Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$2.49
+0.34 (+15.81%)
As of Mar 22, 10:59 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +82.3% upside
Low Target $3.16
Average Target $4.54
High Target $6.69
Current Price $2.49
Current
$2.49
Target
$4.54
$3.16 $4.54 avg $6.69
Scenario Analysis
Bear Case
$3.16
26.9%
Low target
Base Case
$4.54
+82.3%
Avg target
Bull Case
$6.69
+168.7%
High target
Risk/Reward
6.3x
Highly favorable
Price in Context
52-Week High
$9.37
-73.4% from high
52-Week Low
$1.63
+52.8% from low
Target vs 52W High
$4.54
-51.5% vs high
Next Earnings Report
Mar 26, 2026 · Before Market Open
Today
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%